Changes in the nasopharyngeal and oropharyngeal microbiota in pediatric obstructive sleep apnea before and after surgery: a prospective study/Experiment 12

From BugSigDB


Needs review

Curated date: 2024/11/03

Curator: Tosin

Revision editor(s): Tosin

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Throat Gula,Throat,throat
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Obstructive sleep apnea Apnea, Obstructive Sleep,apnea, obstructive sleep,Apneas, Obstructive Sleep,Apneas, obstructive sleep,obstructive sleep apnea,Obstructive Sleep Apnea Syndrome,obstructive sleep apnea syndrome,Obstructive Sleep Apneas,obstructive sleep Apneas,Osa,OSAHS,sleep apnea hypopnea syndrome,Sleep Apnea Syndrome, Obstructive,sleep apnea syndrome, obstructive,Sleep Apnea, Obstructive,sleep apnea/hypopnea syndrome,Sleep Apneas, Obstructive,sleep Apneas, obstructive,Syndrome, Obstructive Sleep Apnea,syndrome, obstructive sleep apnea,Syndrome, Sleep Apnea, Obstructive,syndrome, sleep apnea, obstructive,Syndrome, Upper Airway Resistance, Sleep Apnea,syndrome, upper airway resistance, sleep apnea,Upper Airway Resistance Sleep Apnea Syndrome,upper airway resistance sleep apnea syndrome,Obstructive sleep apnea
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Non Obstructive sleep apnea (OSA)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Obstructive sleep apnea (OSA) Moderate
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants (children) with obstructive apnea hypopnea index [OAHI] severity 6-10 events/h.
Group 0 sample size Number of subjects in the control (unexposed) group
10
Group 1 sample size Number of subjects in the case (exposed) group
10

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2


Signature 1

Needs review

Curated date: 2024/11/03

Curator: Tosin

Revision editor(s): Tosin

Source: Figure S7B

Description: Species differentially abundant in the non-Obstructive sleep apnea (OSA) and Obstructive sleep apnea (OSA) Moderate participants.

Abundance in Group 1: increased abundance in Obstructive sleep apnea (OSA) Moderate

NCBI Quality ControlLinks
Bifidobacteriaceae
Bifidobacteriales
Bifidobacterium
Bulleidia
Cellulomonadaceae
Cellulomonas
Chromatiaceae
Chromatiales
Lachnospiraceae incertae sedis
Novosphingobium
Oscillibacter
Rheinheimera
Roseburia
Rubellimicrobium
Verrucomicrobiota
Ruminococcus

Revision editor(s): Tosin

Signature 2

Needs review

Curated date: 2024/11/03

Curator: Tosin

Revision editor(s): Tosin

Source: Figure S7B

Description: Species differentially abundant in the non-Obstructive sleep apnea (OSA) and Obstructive sleep apnea (OSA) Moderate participants.

Abundance in Group 1: decreased abundance in Obstructive sleep apnea (OSA) Moderate

NCBI Quality ControlLinks
Pseudomonadota
Pasteurellaceae
Pasteurellales
Haemophilus
Betaproteobacteria
Neisseriales
Neisseriaceae
Neisseria
Porphyromonas
Porphyromonadaceae
Leptotrichia
Capnocytophaga
Burkholderiaceae

Revision editor(s): Tosin